France· FR:67311325
NORDIMET 10 mg, solution injectable en stylo prérempli
A medicinal product containing méthotrexate, registered in France by NORDIC GROUP (PAYS-BAS), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MÉTHOTREXATE
- Manufacturer
- NORDIC GROUP (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009300750124 (4x1) stylos préremplis de 0,4 ml avec 4 (4x1) seringues en verre avec 4 (4x1) aiguilles avec 4 (4x1) pistons caoutchouc avec 4 (4x1) tampons alcoolisés (conditionnement multiple)EUR 51.42
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Méthotrexate in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsBasitrin 10 mg=0,267 ml, oplossing voor injectie in een voorgevulde spuit 37,5 mg/mlBasic Pharma Manufacturing B.V.
- IrelandMethofill 10 mg solution for injection in pre-filled injectorAccord Healthcare Ireland Ltd.
- CzechiaFOXIEMOeasyMed s.r.o., Praha 10
- United KingdomEbetrex 10mg/1ml solution for injection pre-filled syringesSandoz Ltd
- SwitzerlandJylamvo
- BelgiumBasitrin 10 mgBasic Pharma Manufacturing
- SpainBERTANEL 10 mg/1 ml SOLUCION INYECTABLE EN JERINGA PRECARGADAEbewe Pharma Ges.M.B.H. Nfg.Kg
- SwedenEbetrex 2,5 mg TablettEBEWE Pharma Ges.m.b.H.Nfg.KG
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Ebetrexat, Methofill
- Belgium · Basitrin, Emthexate
- Bulgaria · Ebetrexat, Инжексат
- Cyprus · Injexate, Methotrexate Accord
- Czechia · Foxiemo, Injexate
- Germany · Lantarel, Lantarel Fs
- Denmark · Ebetrex, Emthexate
- Estonia · Ebetrex, Metex
- Spain · Bertanel, Imeth
- Finland · Ebetrex, Injexate
- United Kingdom (Northern Ireland) · Ebetrex, Injexate
- Greece · Methobion, Methotrexate Pfizer
- Croatia · Ebetrexat, Methofill
- Hungary · Ebetrexat, Methofill
- Ireland · Methofill, Methotrexate Abcur
- Iceland · Jylamvo, Methotrexat Ebewe
- Italy · Afslamet, Immutrex
- Liechtenstein · Jylamvo, Nordimet
- Lithuania · Ebetrexat, Metex
- Luxembourg · Emthexate, Emthexate Teva Pharma
- Latvia · Ebetrex, Metex
- Malta · Methotrexate Aspire Pharma (Malta)
- Netherlands · Basitrin, Ebetrex
- Norway · Ebetrex, Jylamvo
- Poland · Ebetrexat, Metex
- Portugal · Fauldexato, Ledertrexato
- Romania · Methotrexat Ebewe, Metorthrit
- Sweden · Ebetrex, Injexate
- Slovenia · Methofill, Metoject
- Slovakia · Foxiemo, Injexate
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d26152e1-3466-4897-88ee-8a5b4a731dae GET /v1/drugs/d26152e1-3466-4897-88ee-8a5b4a731dae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67311325",
"date_amm": "2016-08-18",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/16/1124",
"substance": "MÉTHOTREXATE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about méthotrexate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.